NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022/23 100% solved - Graded A+
NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022/23 100% solved - Graded A+ 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that applyAge Rapid dose escalation Parental route of administration Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of thefollowing effects? Reduces negative symptoms Increases extra pyramidal symptoms (EPS)Causes prolactinemia Reduces positive symptoms 3. Phencyclidine (PCP) and Ketamine exert their unique behavioral effects by blocking which of thefollowing receptors? GABA type receptors Serotonin receptors Dopamine receptors NMDA type receptors 4. The diagnosis used to describe a syndrome characterized by specific signs and symptoms resultingfrom recent ingestion or exposure to a substance is known as which of the following? Substance intoxication Substance withdrawal Substance use disorderAny of the above 5. Abnormal involuntary movements in a rhythmic pattern affecting face, mouth, tongue, jaw is knownas which of the following? Akathisi a Dystoni a Tardive dyskinesia Extrapyramidalside effects
Escuela, estudio y materia
- Institución
- NRNP 6675-15; NRNP 6675
- Grado
- NRNP 6675-15; NRNP 6675
Información del documento
- Subido en
- 16 de octubre de 2023
- Número de páginas
- 57
- Escrito en
- 2023/2024
- Tipo
- Examen
- Contiene
- Preguntas y respuestas
Temas
- nrnp 6675 15
-
nrnp 6675 15 nrnp 6675 week 6 midterm exam 20222
-
nrnp 6675 week 6 midterm exam 20222
Documento también disponible en un lote